Literature DB >> 21227275

Catecholamine modulation of prefrontal cortical cognitive function.

A F Arnsten1.   

Abstract

The prefrontal cortex (PFC) utilizes working memory to guide behavior and to release the organism from dependence on environmental cues and is commonly disrupted in neuropsychiatric disorders, normal aging, or exposure to uncontrollable stress. This review posits that the PFC is very sensitive to changes in the neuromodulatory inputs it receives from norepinephrine (NE) and dopamine (DA) systems and that this sensitivity can lead to marked changes in the working-memory functions of the PFC. While NE and DA have important beneficial influences on processing in this area, very high levels of catecholamine release, for example, during exposure to uncontrollable stress, disrupt the cognitive functions of the PFC. This fresh understanding of the neurochemical influences on PFC function has led to new treatments for cognitive disorders such as Attention Deficit Hyperactivity Disorder (ADHD), and may help to elucidate the prevalence of PFC dysfunction in other mental disorders.

Entities:  

Year:  1998        PMID: 21227275     DOI: 10.1016/s1364-6613(98)01240-6

Source DB:  PubMed          Journal:  Trends Cogn Sci        ISSN: 1364-6613            Impact factor:   20.229


  129 in total

1.  Effects of neuromodulation in a cortical network model of object working memory dominated by recurrent inhibition.

Authors:  N Brunel; X J Wang
Journal:  J Comput Neurosci       Date:  2001 Jul-Aug       Impact factor: 1.621

2.  Age-Associated Memory Impairment.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-01       Impact factor: 3.598

3.  Organization of working memory processes in monkeys: the effects of a dopamine receptor agonist.

Authors:  K N Dudkin; I V Chueva; M U Arinbasarov; N V Bobkova
Journal:  Neurosci Behav Physiol       Date:  2003-05

4.  Heart rate variability and its relation to prefrontal cognitive function: the effects of training and detraining.

Authors:  Anita Lill Hansen; Bjørn Helge Johnsen; John J Sollers; Kjetil Stenvik; Julian F Thayer
Journal:  Eur J Appl Physiol       Date:  2004-12       Impact factor: 3.078

5.  Social stress reactivity alters reward and punishment learning.

Authors:  James F Cavanagh; Michael J Frank; John J B Allen
Journal:  Soc Cogn Affect Neurosci       Date:  2010-05-07       Impact factor: 3.436

6.  α₂- and β-adrenoceptors involvement in nortriptyline modulation of auditory sustained attention and impulsivity.

Authors:  Swagata Roychowdhury; Zulma Peña-Contreras; Jason Tam; Amulya Yadlapalli; Lu Dinh; Justin Andrew Nichols; Debarshi Basu; Marco Atzori
Journal:  Psychopharmacology (Berl)       Date:  2012-01-21       Impact factor: 4.530

7.  Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.

Authors:  Sargo Aalto; Anna Brück; Matti Laine; Kjell Någren; Juha O Rinne
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

8.  Brainstem abnormalities in attention deficit hyperactivity disorder support high accuracy individual diagnostic classification.

Authors:  Blair A Johnston; Benson Mwangi; Keith Matthews; David Coghill; Kerstin Konrad; J Douglas Steele
Journal:  Hum Brain Mapp       Date:  2014-05-13       Impact factor: 5.038

9.  Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex.

Authors:  Lori A Newman; Jenna Darling; Jill McGaughy
Journal:  Psychopharmacology (Berl)       Date:  2008-06-22       Impact factor: 4.530

10.  Neuroanatomical predictors of L-DOPA response in older adults with psychomotor slowing and depression: A pilot study.

Authors:  Bret R Rutherford; Jongwoo Choi; Mark Slifstein; Kaleigh O'Boyle; Anissa Abi-Dargham; Patrick J Brown; Melanie W Wall; Nora Vanegas-Arroyave; Jayant Sakhardande; Yaakov Stern; Steven P Roose
Journal:  J Affect Disord       Date:  2020-01-15       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.